The Diagnostic Value Of Gd-Eob-Dtpa-Enhanced Mri Scans In Small Hepatocellular Carcinoma In Patients With Liver Cirrhosis

Yingning Wu,Lina Huang,Baosheng Li,Hengguo Li
2020-01-01
Abstract:Objective: To explore the diagnostic value of gadolinium-ethoxybenzyl-diethylenetriamine (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) scanning in small hepatocellular carcinoma in patients with liver cirrhosis. Methods: The selected liver cirrhosis patients were divided into the plain scan (PS) group and the Gd-EOB-DTPA-enhanced (GE) group according to the different detection methods, with 60 cases in each group. The patients in both groups underwent surgery to take biopsy specimens, by which the pathological results were finally determined. The biopsy results and the final diagnosis, the incidences of breathing artifacts in the early and late arterial phases, and the differences in the receiver operator characteristic (ROC) curves in each group were analyzed and compared to explore the diagnostic value of Gd-EOB-DTPA-enhanced MRI scanning in small hepatocellular carcinoma in patients with liver cirrhosis. Results: In the PS group, there were 23 cases diagnosed with hyperplastic nodules, 25 with small hepatocellular carcinoma, and 12 with regenerative nodules. Compared with the final diagnosis of 16 cases with hyperplastic nodules, 39 with small hepatocellular carcinoma and 5 with regenerative nodules, there was a significant difference within the group (P<0.05). In the GE group, there were 6 cases diagnosed with hyperplastic nodules, 49 with small hepatocellular carcinoma and 5 with regenerative nodules. Compared with the final diagnosis of 4 cases with hyperplastic nodules, 50 with small hepatocellular carcinoma, and 6 with regenerative nodules, there was little difference within the groups (P>0.05). There were 6 cases in the PS group and 4 cases in the GE group who presented with breathing artifacts in the early arterial phase, for incidence rates of 10.00% and 6.67%, respectively (P>0.05). Meanwhile, in the late arterial phase, there were 19 cases in the PS group and 8 cases in the GE group who presented with breathing artifacts, for incidence rates of 31.67% and 13.33%, respectively. The incidence of breathing artifacts in the late arterial phase in the PS group was significantly higher than it was in the GE group (P<0.05). The area under the curve (AUC) of the Gd-EOB-DTPA-enhanced MRI scan was 0.806 in patients with small hepatocellular carcinoma, and the diagnostic sensitivity and specificity were 76.64% and 88.32%, respectively. The AUC of the MRI plain scan was 0.791 in patients with small hepatocellular carcinoma, and the diagnostic sensitivity and specificity were 77.74% and 75.35%, respectively (P=0.016). Conclusion: Compared with the MRI plain scan, the Gd-EOB-DTPA-enhanced MRI scan had a higher diagnostic rate and a better diagnostic value in small hepatocellular carcinoma in patients with liver cirrhosis.
What problem does this paper attempt to address?